{
  "resourceType": "RegulatedAuthorization",
  "id": "cfsb2023900992766",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb2023900992766\" </p></div><p><b>identifier</b>: id: EU/1/16/1157/003 (OFFICIAL)</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-cfsb7123030148537.html\">MedicinalProductDefinition/cfsb7123030148537</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072062)</span></p><p><b>description</b>: Suliqua 100 units/ml + 33 microgram/ml solution for injection in x3 pre-filled pens</p><p><b>region</b>: European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#eu)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2017-01-11T13:28:17Z</p><p><b>validityPeriod</b>: 2017-01-11T13:28:17Z --&gt; (ongoing)</p><p><b>holder</b>: <a href=\"Organization-cfsb6005885654359.html\">Organization/cfsb6005885654359</a> \"Sanofi-Aventis Groupe\"</p><p><b>regulator</b>: <a href=\"Organization-cfsb1639015880655.html\">Organization/cfsb1639015880655</a> \"European Medicines Agency\"</p></div>"
  },
  "identifier": [
    {
      "use": "official",
      "system": "https://spor.ema.europa.eu/rmswi/#/",
      "value": "EU/1/16/1157/003"
    }
  ],
  "subject": [
    {
      "reference": "MedicinalProductDefinition/cfsb7123030148537"
    }
  ],
  "type": {
    "coding": [
      {
        "system": "https://spor.ema.europa.eu/rmswi/",
        "code": "/#100000072062"
      }
    ],
    "text": "Marketing Authorisation"
  },
  "description": "Suliqua 100 units/ml + 33 microgram/ml solution for injection in x3 pre-filled pens",
  "region": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "eu"
        }
      ],
      "text": "European Union"
    }
  ],
  "status": {
    "coding": [
      {
        "system": "http://hl7.org/fhir/publication-status",
        "code": "active"
      }
    ],
    "text": "Active"
  },
  "statusDate": "2017-01-11T13:28:17Z",
  "validityPeriod": {
    "start": "2017-01-11T13:28:17Z"
  },
  "holder": {
    "reference": "Organization/cfsb6005885654359"
  },
  "regulator": {
    "reference": "Organization/cfsb1639015880655"
  }
}